Endeavour creates new intermediates for prion drug developers

Endeavour creates new intermediates for prion drug developers

4 Minuten

Beschreibung

vor 14 Jahren
Endeavour Specialty Chemicals has launched a novel range of
pyridinyl thioureas designed to cater for growing pharmaceutical
industry interest in the development of prion disease treatments.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15